Milestone Scientific Inc.
AMEXMilestone Scientific heads into its Q1 results already on the back foot — short sellers spent weeks piling in, then scrambled out just as the company delivered a sales miss. The short-selling story here is the most compelling part of the setup, and its reversal is dramatic. Short interest rocketed from under 100,000 shares in mid-April to a peak of roughly 5.5 million shares around…
MLSS put-call ratio surges to 0.0435, a 4.1 standard deviations above the 20-day mean of 0.0094—the highest level in 52 weeks. Short interest collapsed 58.8% in one week to 1.2% of float, while utilization dropped sharply to 42.2%.
Short interest % of float, cost to borrow, utilization, and put/call ratio for MLSS are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 14 May 2026
Milestone Scientific heads into its Q1 results already on the back foot — short sellers spent weeks piling in, then scrambled out just as the company delivered a sales miss. The short-selling story here is the most…
Milestone Scientific heads into its Q1 2026 earnings aftermath with two sharply diverging signals: shorts have retreated at remarkable speed, while options traders just flashed the most defensive reading on record. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MLSS — free to start on ORTEX.
Sign up for free →Open MLSS on ORTEX